Marketing cooperation and charitable contributions
Gene therapies have the potential to profoundly impact the lives of patients and their families. Here at FinVector, we believe that science is the key to delivering hope and improving the lives of people with chronic health conditions. Today, we want to extend that commitment to serve the unique community that has enabled us to grow and thrive.
Giving back to the community
As a people-first company, we firmly believe that the key to our success lies within our people and their unwavering dedication to their work and the well-being of others.
As part of our communication strategy, we’re all about giving back and more actively contributing to our community. We are looking forward to assisting different organizations, associations, charities and volunteering activities, that are working for the common good of the local community and seeking enablement for their activities.
We are open to making charitable contributions and discussing potential marketing cooperation opportunities with external stakeholders. Charitable contributions are the type of support where we do not expect much in return whereas marketing cooperation, such as collaboration and sponsorships aims to provide opportunities to create value for both parties.
However, there are some limitations to providing support.
- We are supporting the local – our first priority is to lend a hand to stakeholders residing in Finland and preferably in the Kuopio region.
- We are politically and religiously independent – we cannot contribute to activities promoting political or religious views including endorsements and support notifications.
- We act in accordance with our Code of Conduct – we comply with both the substance and the spirit of all local laws, rules, regulations and applicable industry codes.
The application period
We are accepting applications for sponsorships, cooperation opportunities and charitable contributions until December 6th, 2023.
Just as in the GMP world, we will carefully review the documentation sent to us within the given timeframe. The decisions for contributions will be made during the end of 2023.